Literature DB >> 18644986

Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells.

Yeo Kyoung Oh1, Hyun Jung Lee, Mi-Hee Jeong, Marie Rhee, Ji-Won Mo, Eun Hyeon Song, Joong-Yeon Lim, Kyung-Hee Choi, Inho Jo, Sang Ick Park, Bin Gao, Yongil Kwon, Won-Ho Kim.   

Abstract

Taxol (paclitaxel) is a potent anticancer drug that has been found to be effective against several tumor types, including cervical cancer. However, the exact mechanism underlying the antitumor effects of paclitaxel is poorly understood. Here, paclitaxel induced the apoptosis of cervical cancer HeLa cells and correlated with the enhanced activation of caspase-3 and TAp73, which was strongly inhibited by TAp73beta small interfering RNA (siRNA). In wild-type activating transcription factor 3 (ATF3)-overexpressed cells, paclitaxel enhanced apoptosis through increased alpha and beta isoform expression of TAp73; however, these events were attenuated in cells containing inactive COOH-terminal-deleted ATF3 [ATF3(DeltaC)] or ATF3 siRNA. In contrast, paclitaxel-induced ATF3 expression did not change in TAp73beta-overexpressed or TAp73beta siRNA-cotransfected cells. Furthermore, paclitaxel-induced ATF3 translocated into the nucleus where TAp73beta is expressed, but not in ATF3(DeltaC) or TAp73beta siRNA-transfected cells. As confirmed by the GST pull-down assay, ATF3 bound to the DNA-binding domain of p73, resulting in the activation of p21 or Bax transcription, a downstream target of p73. Overexpression of ATF3 prolonged the half-life of TAp73beta by inhibiting its ubiquitination and thereby enhancing its transactivation and proapoptotic activities. Additionally, ATF3 induced by paclitaxel potentiated the stability of TAp73beta, not its transcriptional level. Chromatin immunoprecipitation analyses show that TAp73beta and ATF3 are recruited directly to the p21 and Bax promoter. Collectively, these results reveal that overexpression of ATF3 potentiates paclitaxel-induced apoptosis of HeLa cells, at least in part, by enhancing TAp73beta's stability and its transcriptional activity. The investigation shows that ATF3 may function as a tumor-inhibiting factor through direct regulatory effects on TAp73beta, suggesting a functional link between ATF3 and TAp73beta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644986      PMCID: PMC3783268          DOI: 10.1158/1541-7786.MCR-07-0297

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  47 in total

Review 1.  p53 family update: p73 and p63 develop their own identities.

Authors:  M S Irwin; W G Kaelin
Journal:  Cell Growth Differ       Date:  2001-07

Review 2.  Transcription factors as potential targets for therapeutic drugs.

Authors:  D S Latchman
Journal:  Curr Pharm Biotechnol       Date:  2000-07       Impact factor: 2.837

3.  ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms.

Authors:  B P Chen; G Liang; J Whelan; T Hai
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

4.  Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

Authors:  S S Bacus; A V Gudkov; M Lowe; L Lyass; Y Yung; A P Komarov; K Keyomarsi; Y Yarden; R Seger
Journal:  Oncogene       Date:  2001-01-11       Impact factor: 9.867

5.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

6.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

7.  Stabilization of p73 by nuclear IkappaB kinase-alpha mediates cisplatin-induced apoptosis.

Authors:  Kazushige Furuya; Toshinori Ozaki; Takayuki Hanamoto; Mitsuchika Hosoda; Syunji Hayashi; Philip A Barker; Kunio Takano; Masahiko Matsumoto; Akira Nakagawara
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

Review 8.  Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.

Authors:  R Foa; L Norton; A D Seidman
Journal:  Int J Clin Lab Res       Date:  1994

9.  Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes.

Authors:  Shohreh Amini; Marcus Saunders; Kimberly Kelley; Kamel Khalili; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

Review 10.  Paclitaxel (Taxol) in breast cancer.

Authors:  S G Arbuck; A Dorr; M A Friedman
Journal:  Hematol Oncol Clin North Am       Date:  1994-02       Impact factor: 3.722

View more
  15 in total

1.  The protein Zfand5 binds and stabilizes mRNAs with AU-rich elements in their 3'-untranslated regions.

Authors:  Guoan He; Dongxu Sun; Zhiying Ou; Aihao Ding
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis.

Authors:  Yi Seok Chang; Swati P Jalgaonkar; Justin D Middleton; Tsonwin Hai
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

3.  The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.

Authors:  Yuxing Zhu; Dong He; Hao Bo; Zexian Liu; Mengqing Xiao; Liang Xiang; Jianda Zhou; Yan Liu; Xiaoming Liu; Lian Gong; Yanni Ma; Yanhong Zhou; Ming Zhou; Wei Xiong; Fei Yang; Xiaowei Xing; Ruhong Li; Wei Li; Ke Cao
Journal:  Oncogene       Date:  2019-07-04       Impact factor: 9.867

4.  Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.

Authors:  Hongbo Wang; Pingli Mo; Shumei Ren; Chunhong Yan
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

5.  Activating transcription factor 3 mediates apoptotic functions through a p53-independent pathway in human papillomavirus 18 infected HeLa cells.

Authors:  Abolfazl Kooti; Haniyeh Abuei; Ali Farhadi; Abbas Behzad-Behbahani; Maryam Zarrabi
Journal:  Virus Genes       Date:  2022-02-07       Impact factor: 2.332

6.  Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.

Authors:  Ibrahim Knani; Preeti Singh; Miriam Gross-Cohen; Sharon Aviram; Neta Ilan; Ralph D Sanderson; Ami Aronheim; Israel Vlodavsky
Journal:  Matrix Biol       Date:  2021-11-20       Impact factor: 11.583

7.  The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.

Authors:  Saisai Wei; Hongbo Wang; Chunwan Lu; Sarah Malmut; Jianqiao Zhang; Shumei Ren; Guohua Yu; Wei Wang; Dale D Tang; Chunhong Yan
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

8.  ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy.

Authors:  Kathryn G Eby; Jennifer M Rosenbluth; Deborah J Mays; Clayton B Marshall; Christopher E Barton; Seema Sinha; Kimberly N Johnson; Luojia Tang; Jennifer A Pietenpol
Journal:  Mol Cancer       Date:  2010-04-29       Impact factor: 27.401

9.  Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.

Authors:  Christina Hackl; Sven A Lang; Christian Moser; Akira Mori; Stefan Fichtner-Feigl; Claus Hellerbrand; Wolfgang Dietmeier; Hans J Schlitt; Edward K Geissler; Oliver Stoeltzing
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

10.  Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages.

Authors:  Rui Medeiros; Bruno Horta; Joana Freitas-Silva; Jani Silva; Francisca Dias; Emília Sousa; Madalena Pinto; Fátima Cerqueira
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.